NB
Neerav Bansal
About Neerav Bansal
Data last updated:
Neerav Bansal is a Director at 3Q Medicine Private Limited (since 2016) and Director at Million Hearts Foundation (since 2018). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹38.6 Lakh; the largest is 3Q Medicine Private Limited at ₹29.2 Lakh (FY 2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Apr 2016 | 2014 | ₹29.2 Lakh (FY 2017) | Active | |
| Director | 05 Mar 2018 | 2018 | ₹9.4 Lakh (FY 2024) | Active |
Board colleagues of Neerav Bansal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Biju Sivam Pillai | 06764764 | 3Q Medicine Private Limited , Million Hearts Foundation | Director |
| Kanwar Aditya Baloria | 06764768 | 3Q Medicine Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Neerav Bansal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neerav Bansal
Neerav Bansal currently holds 2 directorships: 3Q Medicine Private Limited (Director, since 01 Apr 2016, revenue ₹29.2 Lakh (FY 2017)); Million Hearts Foundation (Director, since 05 Mar 2018, revenue ₹9.4 Lakh (FY 2024)).
Neerav Bansal was first appointed on 01 Apr 2016 as Director at 3Q Medicine Private Limited. The most recent appointment on record is 05 Mar 2018 at Million Hearts Foundation.
The 2 current companies of Neerav Bansal that report revenue have a combined latest revenue of ₹38.6 Lakh: 3Q Medicine Private Limited ₹29.2 Lakh (FY 2017); Million Hearts Foundation ₹9.4 Lakh (FY 2024).
The current boards of Neerav Bansal's companies include Biju Sivam Pillai (3Q Medicine Private Limited), Kanwar Aditya Baloria (3Q Medicine Private Limited).